KEI Comments in response to the Office of Science and Technology Policy (OSTP) Request for Information (RFI), regarding National Priorities for Artificial Intelligence, as noticed on May 23, 2023 in the Federal Register, 88 FR 34194. July 7, 2023 Knowledge… Continue Reading →
In 2020, KEI filed a citizens petition with the FDA, asking for a rule banning the use of background music during the presentation of the risks in direct to consumer drug advertising. The 2020 KEI petition is here: https://www.regulations.gov/document/FDA-2020-P-1725-0001 The… Continue Reading →
Today, eight non-governmental organizations sent the Biden Administration a letter of support for the administrative appeal of the request for the Department of Health and Human Services (HHS) to use its rights in the patents on the prostate cancer drug… Continue Reading →
On 17 April 2023, Knowledge Ecology International, delivered the following statement on proposed amendments to the International Health Regulations. Our statement focused on the Africa Group’s proposal on a new Article 13A on Access to Health Products, Technologies and Know-How… Continue Reading →
Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – March/April 2023 2 February 2023, Reuters, Draft WHO pandemic deal pushes for equity to avoid COVID ‘failure’ repeat, By Jennifer Rigby and Gabrielle Tétrault-Farber. However, there will… Continue Reading →
(UPDATE: A recording of the event is available on our YouTube channel here: https://www.youtube.com/watch?v=_qFgm-dohuU) Date: Thursday April 20, 2023 Time: 1:30 PM to 3:00 PM EDT Knowledge Ecology International is hosting an online discussion of two Bayh-Dole safeguard related topics.… Continue Reading →
Attached is an April 5, 2023 letter to the Biden Administration requesting a reversal of the United States’ position on restricting public access to the drafts of the negotiating texts of the WHO pandemic accord. The letter is signed by… Continue Reading →
On March 23, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, filed an administrative appeal of the NIH decision to reject petition that HHS use Federal rights in patents on Xtandi to address pricing discrimination against… Continue Reading →
NIH-rejection-Xtandi-marchin-21march2023 This is an appalling decision. The worst is this quote: “practical application is evidenced by the “manufacture, practice, and operation” of the invention and the invention’s “availability to and use by the public….” This is what 35 USC 201(f)… Continue Reading →
Patents, and technology Transfer WIPO Model Law for Developing Countries on Inventions, 1965. United International Bureaux for the Protection of Intellectual of Intellectual Property (B.I.R.P.I). 1965. (link) WIPO Model Law For Developing Countries on Inventions, Vol 1. Patents, 1979 WIPO… Continue Reading →